DC
CTIC

Deere & Company’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Deere & Company’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,250
Closed -$552K – 1123
2014
Q1 		$552K Buy
+16,250
New +$555K 0.03% 602

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deere & Company's CTIC Position: Q2 2014 in Review

Deere & Company sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2014, closing a stake of 16,250 shares — an estimated $552K sold.

Deere & Company first reported a position in CTIC in Q1 2014 and held it in 1 quarter. The position peaked at $552K in Q1 2014. 89 funds tracked by Wall St. Rank hold CTIC as of Q2 2014.

  • Deere & Company reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2014 after selling out during the quarter.
  • Deere & Company sold 16,250 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2014, an estimated $552K.
  • Deere & Company first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 1 quarter.
  • Deere & Company's CTI BioPharma Corp. (DE) Common Stock position peaked at $552K in Q1 2014.
  • 89 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2014.

Based on Deere & Company's 13F filing for Q2 2014, filed 11 Aug 2014.